Reduced anticoagulation after mechanical aortic valve replacement: Interim results from the Prospective Randomized On-X Valve Anticoagulation Clinical Trial randomized Food and Drug Administration investigational device exemption trial
Keywords: 18; 2; 35; AVR; aortic valve replacement; INR; international normalized ratio; PROACT; Prospective Randomized On-X Anticoagulation Clinical Trial; pt-yrs; patient-years; TE; thromboembolism; TIA; transient ischemic attack;